Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at the IASLC 2021 World Conference on Lung Cancer

NEXT STORY
Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
PREV STORY
Wound Closure Devices Market Research Report by End-user, by Product, by Wound Type, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax ASA: Second quarter and first half 2017 results

Oslo, Norway, 24 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company ...

author_avatar
NASDAQ Market News

TESARO Announces Participation at Three Investor Conferences

WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused ...

author_avatar
NASDAQ Market News

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid ...

author_avatar
NASDAQ Market News